BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:05 PM
 | 
Apr 28, 2009
 |  BC Extra  |  Clinical News

Debiopharm reports Phase IIa HCV data

In an open-label Phase IIa trial, 400 and 800 mg doses of Debio 025 from Debiopharm S.A. (Lausanne, Switzerland) plus...

Read the full 88 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >